ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $506,000 | +8.8% | 102,991 | +16.9% | 0.00% | – |
| Q2 2021 | $465,000 | +8.9% | 88,115 | -1.1% | 0.00% | – |
| Q1 2021 | $427,000 | +43.3% | 89,061 | +29.7% | 0.00% | – |
| Q4 2020 | $298,000 | +1.7% | 68,649 | -3.6% | 0.00% | – |
| Q3 2020 | $293,000 | +68.4% | 71,193 | +4.8% | 0.00% | – |
| Q2 2020 | $174,000 | -79.4% | 67,916 | -76.8% | 0.00% | – |
| Q1 2020 | $846,000 | -21.6% | 292,717 | +2.8% | 0.00% | – |
| Q4 2019 | $1,079,000 | -25.4% | 284,831 | +0.8% | 0.00% | – |
| Q3 2019 | $1,446,000 | -14.0% | 282,546 | +4.1% | 0.00% | – |
| Q2 2019 | $1,682,000 | -12.7% | 271,430 | +0.2% | 0.00% | – |
| Q1 2019 | $1,926,000 | -20.1% | 270,844 | -4.1% | 0.00% | -100.0% |
| Q4 2018 | $2,411,000 | -58.0% | 282,285 | -1.5% | 0.00% | 0.0% |
| Q3 2018 | $5,740,000 | -19.1% | 286,716 | +4.4% | 0.00% | -50.0% |
| Q2 2018 | $7,092,000 | +33.1% | 274,563 | +23.1% | 0.00% | +100.0% |
| Q1 2018 | $5,330,000 | -20.5% | 223,055 | +12.7% | 0.00% | -50.0% |
| Q4 2017 | $6,706,000 | +61.9% | 197,888 | +1.2% | 0.00% | +100.0% |
| Q3 2017 | $4,141,000 | +22.5% | 195,599 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $3,380,000 | -5.2% | 193,272 | -5.2% | 0.00% | 0.0% |
| Q1 2017 | $3,567,000 | +5.9% | 203,819 | +2.3% | 0.00% | 0.0% |
| Q4 2016 | $3,368,000 | +6.7% | 199,298 | +3.6% | 0.00% | 0.0% |
| Q3 2016 | $3,157,000 | +10.0% | 192,353 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $2,870,000 | +42.3% | 189,600 | +35.9% | 0.00% | 0.0% |
| Q1 2016 | $2,017,000 | -40.5% | 139,514 | +16.5% | 0.00% | 0.0% |
| Q4 2015 | $3,391,000 | +68.4% | 119,715 | -0.5% | 0.00% | 0.0% |
| Q3 2015 | $2,014,000 | +47.9% | 120,335 | +131.7% | 0.00% | – |
| Q2 2015 | $1,362,000 | +102.1% | 51,929 | +34.6% | 0.00% | – |
| Q1 2015 | $674,000 | +23.0% | 38,572 | +22.3% | 0.00% | – |
| Q4 2014 | $548,000 | -7.7% | 31,541 | -1.1% | 0.00% | – |
| Q3 2014 | $594,000 | +209.4% | 31,899 | +203.9% | 0.00% | – |
| Q2 2014 | $192,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|